DAVID KLIBANOFF
Prescription History 1275501421
Optometrist in Pawtucket, RI

Active since March 12, 2006PECOS Enrolled
121 BROAD ST, PAWTUCKET, RI 02860(401) 723-3400(401) 727-2326 Get Directions

NPPES record last updated: May 20, 2008. Verified against the NPPES registry weekly; last sync: August 09, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DAVID KLIBANOFF, an active Optometrist specialist practicing in Pawtucket, RI. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 151 documented patient claims. Among these therapy options, the most frequently utilized medication is Travoprost, which accounts for 55 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

5
Medications
151
Total Claims
229
30-Day Fills
Travoprost
Most Prescribed · 55 claims
View details
5 medications · 2023 Medicare Part D
Medicare Part D medications prescribed by DAVID KLIBANOFF in 2023, with prescription volumes, average cost per fill, and RI state comparisons
Medication Prescriptions (2023)Rx (2023) Avg Cost per FillCost / Fill Vs. Other RI PrescribersVs. RI Avg

About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾

Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

In 2023, this provider wrote 55 Medicare prescriptions for Travoprost, about 1.9 times the volume of the typical Rhode Island prescriber of this medication (29). Medicare paid an average of $191.08 per fill, versus $223.26 statewide.

How often this provider prescribes it

This provider
55
RI average
29.0

This provider prescribes this medication more often than the average RI prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$191.08
RI average
$223.26

This provider's average cost per fill is below the RI average for this medication.

69
30-Day Fills
standardized to 30-day supplies
1,883
Days of Medication
total across all patients in 2023

About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾

It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA.

In 2023, this provider wrote 41 Medicare prescriptions for Latanoprost, about a quarter of the volume of the typical Rhode Island prescriber of this medication (147). Medicare paid an average of $37.15 per fill, versus $23.24 statewide.

How often this provider prescribes it

This provider
41
RI average
147.0

This provider prescribes this medication less often than the average RI prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$37.15
RI average
$23.24

Gross Part D cost per fill; not the patient's out-of-pocket price.

79.2
30-Day Fills
standardized to 30-day supplies
2,259
Days of Medication
total across all patients in 2023

About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾

Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

In 2023, this provider wrote 27 Medicare prescriptions for Brimonidine Tartrate, about half the volume of the typical Rhode Island prescriber of this medication (55). Medicare paid an average of $22.26 per fill, versus $40.93 statewide.

How often this provider prescribes it

This provider
27
RI average
55.0

This provider prescribes this medication less often than the average RI prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$22.26
RI average
$40.93

This provider's average cost per fill is below the RI average for this medication.

47.7
30-Day Fills
standardized to 30-day supplies
1,430
Days of Medication
total across all patients in 2023

About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾

Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors.

In 2023, this provider wrote 16 Medicare prescriptions for Dorzolamide-Timolol, about a quarter of the volume of the typical Rhode Island prescriber of this medication (70). Medicare paid an average of $13.10 per fill, versus $33.49 statewide.

How often this provider prescribes it

This provider
16
RI average
70.0

This provider prescribes this medication less often than the average RI prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$13.10
RI average
$33.49

This provider's average cost per fill is below the RI average for this medication.

20.8
30-Day Fills
standardized to 30-day supplies
625
Days of Medication
total across all patients in 2023

About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾

This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

In 2023, this provider wrote 12 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about a third of the volume of the typical Rhode Island prescriber of this medication (41). Medicare paid an average of $10.95 per fill, versus $13.71 statewide.

How often this provider prescribes it

This provider
12
RI average
41.0

This provider prescribes this medication less often than the average RI prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$10.95
RI average
$13.71

This provider's average cost per fill is below the RI average for this medication.

12
30-Day Fills
standardized to 30-day supplies
210
Days of Medication
total across all patients in 2023
No medications match the current filters.
More than typical Typical Less than typical= prescription volume vs the average RI prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the RI average cost per fill.

About this data. The prescription history for DAVID KLIBANOFF is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Pawtucket, RI practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among RI prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.